Basics |
Alto Neuroscience Inc.
|
IPO Date: |
February 2, 2024 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$69.58M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.34 | 4.03%
|
Avg Daily Range (30 D): |
$0.09 | 3.51%
|
Avg Daily Range (90 D): |
$0.10 | 4.04%
|
Institutional Daily Volume |
Avg Daily Volume: |
.28M |
Avg Daily Volume (30 D): |
.19M |
Avg Daily Volume (90 D): |
.2M |
Trade Size |
Avg Trade Size (Sh.): |
106 |
Avg Trade Size (Sh.) (30 D): |
133 |
Avg Trade Size (Sh.) (90 D): |
121 |
Institutional Trades |
Total Inst.Trades: |
68 |
Avg Inst. Trade: |
$1.64M |
Avg Inst. Trade (30 D): |
$1.39M |
Avg Inst. Trade (90 D): |
$1.26M |
Avg Inst. Trade Volume: |
.17M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.39M |
Avg Closing Trade (30 D): |
$3.88M |
Avg Closing Trade (90 D): |
$2.32M |
Avg Closing Volume: |
348.46K |
|
|
News |
Jul 23, 2025 @ 2:00 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: Pomerantz Llp
|
Jul 22, 2025 @ 10:49 PM
ALTO CLASS ACTION ALERT: Bragar Eagel & Squire, P....
Source: Bragar Eagel & Squire, P.C.
|
Jul 22, 2025 @ 10:25 PM
ALTO NEUROSCIENCE, INC. (NYSE: ANRO) INVESTOR ALER...
Source: Bernstein Liebhard Llp
|
Jul 22, 2025 @ 8:00 PM
ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman Llc
|
Jun 3, 2025 @ 6:48 PM
Alto Neuroscience Adds 'Intriguing' Depression Ass...
Source: Vandana Singh
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-2.34
|
$-.56
|
$-.56
|
Diluted EPS
|
$-2.34
|
$-.56
|
$-.56
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -63.18M
|
$ -15.17M
|
$ -15.2M
|
Operating Income / Loss
|
$ -69.9M
|
$ -15.68M
|
$ -17M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -44.64M
|
$ -7.48M
|
$ -13.47M
|
PE Ratio
|
|
|
|
|
|
|